ABOS - Company ID 0001576885
The table below shows Acumen Pharmaceuticals, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $53.99M | $35.63M | $66.89M | - | $122.16M |
| Short-term investments | $62.88M | $135.93M | $176.64M | $47.50M | $72.08M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $122.25M | $178.31M | $246.62M | $180.33M | $198.66M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $103.00K | $73.00K | - | $165.00K | $36.00K |
| Goodwill | - | - | - | - | - |
| Total assets | $122.83M | $238.99M | $310.13M | $196.59M | $230.33M |
| Accounts payable | $554.00K | $5.65M | $1.38M | $1.64M | $1.09M |
| Total current liabilities | $30.01M | $27.61M | $12.97M | $7.81M | - |
| Long-term debt | $22.40M | $29.42M | $29.90M | - | - |
| Total liabilities | $52.40M | $57.18M | $43.15M | $7.81M | $5.15M |
| Retained earnings | -$446.46M | -$325.13M | -$222.80M | -$170.43M | -$127.57M |
| Total equity | $70.43M | $181.82M | $266.97M | $188.78M | $225.18M |